Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
[Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
A Drouet1, F Le Moigne2, D Salamé3
1Service de neurologie, HIA Desgenettes, 108, boulevard Pinel, 69275 Lyon cedex 3, France; Centre de compétence neurofibromatose, Rhône-Alpes-Auvergne, centre Léon Bérard, 28, rue Laënnec, 69373 Lyon cedex 08, France.
Neurofibromatosis type 2 (NF2) mosaicism can present with severe symptoms, not just mild forms. Early ophthalmological screening is crucial for at-risk children to ensure timely diagnosis and management of NF2.
Area of Science:
- Genetics
- Oncology
- Ophthalmology
Background:
- Neurofibromatosis type 2 (NF2) is a rare, dominantly inherited disorder with variable clinical presentations.
- Early diagnosis of NF2 is challenging due to differing adult and pediatric manifestations.
- Molecular analysis of the NF2 gene aids diagnosis but may yield negative results in mosaicism.
More Related Videos
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pedigree Analysis
Type II Diabetes I: Introduction
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Incomplete Dominance

